Navigation Links
Chinese medicine leaflet broke advertising code

A leaflet claiming that traditional Chinese medicine was safer than western alternatives // has breached the advertising code in the UK, an industry watchdog said on Wednesday.

The leaflet could dissuade patients from seeking essential treatment from qualified doctors for serious medical conditions, the Advertising Standards Authority (ASA) said.

The leaflet, produced by Ever Well Ltd, also claimed that serious medical problems such as cancer could be treated with Chinese medicine. It claimed that Everwell clinics could effectively cure all 66 conditions or symptoms listed in the leaflet - from lung cancer and infertility to acne and depression.

The Medicines and Healthcare products Regulatory Agency (MHRA)—a government agency responsible for ensuring medicines are safe and effective—challenged whether Ever Well could treat all the medical conditions listed, and its implication that Chinese medicine was safer.

MHRA head of herbals policy, Richard Woodfield said the agency was writing to the herbal medicine associations encouraging members to check advertising complied with the code.

He said the agency had complained to the ASA because of concern that the claims of safety made by traditional Chinese medicine clinics were unsubstantiated.

The ASA said the use of the word "doctor" in the leaflet misleadingly implied the practitioners held general medical qualifications. It told the company not to claim that particular medical conditions could be treated by Chinese medicine unless they could prove it. It warned against repetition of the assertion that Chinese medicine was safer than western medicines.

Ever Well, on its part, argued there was a wealth of evidence that traditional Chinese medicine was a viable alternative to Western methods.

The company also said the leaflet did not state that Ever Well could effectively treat the illnesses listed, but that the ailments were capable of being treated.
'"/>




Page: 1 2

Related medicine news :

1. Chinese paracetamol may be slapped with dumping duty
2. Stay young the Chinese way
3. A Chinese herb kills cancer cells
4. Chinese herbal remedies aids in cancer treatment
5. Prohibited diet medicine found in Chinese herbs
6. Global Outbreak Of Bird Flu Warning By Chinese Scientist
7. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
8. Unscrupulous Chinese Medicine traders putting lives at risk
9. Chinese City Suspends Water Supply Fearing Pollution
10. Running Water Restored In Chinese City
11. Mass Bird flu vaccination to Chinese Poultry
Post Your Comments:
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2
...r the first time, a new study has looked into how ...derstand and retell a script-based story. , When...ing to a restaurant, we remember the kinds of acti...are listening to a story that takes place at a res...
...sudden loss of T cells -- white blood cells crucia...he onset of AIDS, according to a study published i...ology by a team of researchers at Tulane National ... current thinking regarding AIDS, namely that a su...
...NGTON, Sept. 21 Business Roundtable and,the Ameri...h the,Roundtable,s Partnership for Disaster Respon...the business community to contribute its vast,reso...ement is timed with National Preparedness Month, a...
...ned National Security Facility to Offer EHR-Enhanc...tration/Billing for 8,500 Employees ...ghlights Growing Trend of Computer-Enhanced Onsite...linical software and,information solutions that ph...
...IEGO, Sept. 21 ChemDiv, Inc. (San Diego) announce...tute (CDRI, Moscow) is,undertaking a partnership w...the Russian Academy of Medical Sciences, the US De...state cancer,(PRC). The partnership will operate u...
...WOOD, Colo., Sept. 21 Baxa Corporation, a leading...elivery in hospital,pharmacies, announces the addi.... These agreements -- with Magallan Pharma Trading... South,America and the Caribbean. "Global markets...
Other Medicine News:Health News:Progression of SIV infection in monkeys raises 2Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 2Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 3Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 4Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 2Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 3Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 4Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 2Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 3Health News:Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 2
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 1Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 3Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 4Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 6Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 7Stent Studies Tied to Rapid Changes in Use 52992 1Stent Studies Tied to Rapid Changes in Use 52992 2DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
...27 A doctor who is,internationally recognized for...cally for research on DHA, an omega-3 fatty acid, ...d for outstanding achievement in the field,of mate...as among the first to report that infants,receivin...oic acid) levels,than formula-fed infants and the ...
...ur Years of Treatment Presented at ICAAC/IDSA,2008...ough,Corporation (NYSE: SGP ) today reported a da...tional CCR5 receptor antagonist, demonstrated,sust...nts and was well,tolerated through up to four year... patients. Vicriviroc was administered once-daily ...
Other Medicine Technology:March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition 2Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 2Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 3Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 4Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 5Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 6
DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid
DNA Engine Thermal Cycler Chassis
MBS Satellite Thermal Cycler 0.5ml
MBS Satellite Thermal Cycler 0.2ml
Medicine Products: